US Anticoagulant and Antiplatelet Therapies ... - Frost & Sullivan

crunchkingofprussiaBiotechnology

Dec 6, 2012 (4 years and 4 months ago)

146 views

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

U.S. Anticoagulant and Antiplatelet
Therapies Markets



New Generation Therapies Signify Market Growth


"The growing patient uptake of innovative and costly anticoagulants and antiplatelets
coupled with the exploration of opportunities in under
-
served, niche markets, drive the
growth of the anti
-
clotting therapies market in the United States.”

Pharmaceutical Biotech Analyst Team

Frost & Sullivan

© Copyright 2002 Frost & Sullivan. All Rights Reserved.



Frost & Sullivan provides:




Detailed insights into recent developments and trends




Drivers, restraints, challenges, and strategic recommendations




Analyst insights on ‘hot topics’ and emerging applications


in the
anticoagulant and antiplatelet therapies

market




Market sizing and competitive analysis




Market forecasts and opportunity analysis




Quarterly assessments




End user analysis within each report

Key Features

© Copyright 2002 Frost & Sullivan. All Rights Reserved.



Coverage: The United States



Proven methodology encompassing extensive primary and
secondary data and research



Focused information and strategies that cover business and
technology issues



Credible data and analysis highlighting industry dynamics



Winning strategies to help you create precise business plans

What We Offer

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Current Market Participants


Find out how you compare to the competition


Assess current and future drivers and restraints


Determine and exploit new market share opportunities


New Entrants



Analyze challenges associated with the industry


Calculate time scales for strategy implementation


Position yourself to capitalize on the market’s unmet needs


Investment Community


Analyze long
-
term strategies of companies


Determine which participants will outperform the competition


Assess attractiveness of investing in the market

Who Will Benefit?

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

3
-
Dimensional Pharmaceuticals, Inc.

Abbott Laboratories

Akzo Nobel nv

American Biogenetic Sciences

American Heart Association, Inc.

AstraZeneca Pharmaceuticals LP

Aventis Pharmaceuticals, Inc.

Berlex Laboratories, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Bristol
-
Myers Squibb Co.

Centocor, Inc.

Corvas International, Inc.

Eli Lilly & Co.

Emisphere Technologies, Inc.

Eon Laboratories, Inc.


GlaxoSmithKline

GlycoDesign, Inc.

La Jolla Pharmaceutical Co.

Merck & Co.

Millennium Pharmaceuticals, Inc.

Mitsubishi Pharma America, Inc.

Par Pharmaceutical, Inc.

Pharmacia Corp.

Roche Pharmaceuticals

Sanofi
-
Synthelabo, Inc.

Schering
-
Plough Corp.

Taro Pharmaceuticals USA, Inc.

Texas Biotechnology Corp.

The Medicines Co.

Yamanouchi Pharma America, Inc.



Key Market Participants

© Copyright 2002 Frost & Sullivan. All Rights Reserved.



Call toll free

877
G
O

F
ROST





(877.463.7876)



Fax toll free

888.690.3329



E
-
mail

myfrost@frost.com



Visit

www.frost.com


For More Information